BRICK, N.J., Sept. 29, 2005 (PRIMEZONE) -- Franchise Management International Inc. (Pink Sheets:FMII) signed an exclusive Distributorship Agreement with Terra-Therapy Inc.
FMII is working very closely with Robert Ortiz, MD, FICPS, CEO of Terra-Therapy, Inc. who holds U.S. Patent No. 6,352,691B1 as well as several registered trademarks. Dr. Ortiz developed the product AfterCARE(tm). The AfterCARE(tm) Hair Removal Skin Care Cream represents the first of several future innovative patentable products in the making. It clearly combines a very effective and well-established anti-inflammatory agent with some of the most popular and successful remedies arising from alternative medicine industry.
"This product goes a long way in our strategy. We are building the mortar for our home-based agents business. This product is an excellent building block to that end," says Pat Guadagno, the President of Franchise Management International Inc. "Our strategy is to get home-based agents as part of our Company and a low cost of entry with an emphasis on service is a key to achieving that goal. We are taking advantage of connectivity in homes and on the road."
Statements included in this release are not historical in nature constitute forward-looking statements for the purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Readers are cautioned that any information on this contains certain such forward-looking statements that involve substantial risks and uncertainties. When used, the words "anticipate," "believe," "estimate," "expect," and similar expressions as they relate to any company or its management are intended to identify such forward-looking statements. Our company's actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward looking statements.